1. Home/
  2. Compounds/
  3. BRD-K27188169:navitoclax (2:1 mol/mol)

BRD-K27188169:navitoclax (2:1 mol/mol)


SourcesNames Used
CTRPv2BRD-K27188169:navitoclax (2:1 mol/mol)
PharmacoGx BRD-K27188169:navitoclax (2:1 mol/mol)

Cell lines tested with BRD-K27188169:navitoclax (2:1 mol/mol)

373 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
IGROV-1 ovary CTRPv22
P3HR-1 haematopoietic and lymphoid tissue CTRPv22
CAL-51 breast CTRPv22
NCI-H460 lung CTRPv22
NCI-H1299 lung CTRPv22
SUIT-2 pancreas CTRPv22
A375 skin CTRPv22
ZR-75-1 breast CTRPv21
YAPC pancreas CTRPv21
Download CSV

Tissues tested with BRD-K27188169:navitoclax (2:1 mol/mol)

24 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv272
large intestineCTRPv227
central nervous systemCTRPv221
urinary tractCTRPv215
Download CSV
Download Data as CSV

Top molecular features associated with response to BRD-K27188169:navitoclax (2:1 mol/mol)

Feature TypeStandardized
Nominal ANOVA
mRNA CARD16 CTRPv2 AAC -2.6e-05 1
mRNA AC009133.22 CTRPv2 AAC -2.7e-05 1
mRNA STARD3 CTRPv2 AAC -2.2e-05 1
mRNA ATG14 CTRPv2 AAC 1.8e-05 1
mRNA CUL4A CTRPv2 AAC -1.7e-05 1
mRNA AC092718.1 CTRPv2 AAC -1.7e-05 1
mRNA HGFAC CTRPv2 AAC 1.5e-05 1
mRNA SYNGR3 CTRPv2 AAC -1.4e-05 1
mRNA TNNT2 CTRPv2 AAC 1.7e-05 1
mRNA DSG1 CTRPv2 AAC -1.2e-05 1
Download CSV